Cargando…
Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
Reports suggest an increased risk of tuberculosis (TB) in people with chronic airway diseases (CADs) such as chronic obstructive pulmonary disease (COPD), but evidence has not been systematically reviewed. We performed a systematic review by searching MEDLINE and Embase for studies published from 1...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070518/ https://www.ncbi.nlm.nih.gov/pubmed/34383072 http://dx.doi.org/10.1093/trstmh/trab122 |
_version_ | 1784700657853267968 |
---|---|
author | Hamada, Yohhei Fong, Christopher J Copas, Andrew Hurst, John R Rangaka, Molebogeng X |
author_facet | Hamada, Yohhei Fong, Christopher J Copas, Andrew Hurst, John R Rangaka, Molebogeng X |
author_sort | Hamada, Yohhei |
collection | PubMed |
description | Reports suggest an increased risk of tuberculosis (TB) in people with chronic airway diseases (CADs) such as chronic obstructive pulmonary disease (COPD), but evidence has not been systematically reviewed. We performed a systematic review by searching MEDLINE and Embase for studies published from 1 January 1993 to 15 January 2021 reporting the association between the incident risk of TB in people with CADs (asthma, COPD and bronchiectasis). Two reviewers independently assessed the quality of individual studies. We included nine studies, with two from low-income high TB burden countries. Three cohort studies reported a statistically significant independent association between COPD and the risk of TB in high-income countries (n=711 389). Hazard ratios for incident TB ranged from 1.44 to 3.14 adjusted for multiple confounders including age, sex and comorbidity. There was large between-study heterogeneity (I(2)=97.0%) across studies. The direction of effect on the TB risk from asthma was inconsistent. Chronic bronchitis or bronchiectasis studies were limited. The small number of available studies demonstrated an increased risk of TB in people with COPD; however, the magnitude of the increase varies by setting and population. Data in high TB burden countries and for other CADs are limited. |
format | Online Article Text |
id | pubmed-9070518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-90705182022-05-06 Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence Hamada, Yohhei Fong, Christopher J Copas, Andrew Hurst, John R Rangaka, Molebogeng X Trans R Soc Trop Med Hyg Review Article Reports suggest an increased risk of tuberculosis (TB) in people with chronic airway diseases (CADs) such as chronic obstructive pulmonary disease (COPD), but evidence has not been systematically reviewed. We performed a systematic review by searching MEDLINE and Embase for studies published from 1 January 1993 to 15 January 2021 reporting the association between the incident risk of TB in people with CADs (asthma, COPD and bronchiectasis). Two reviewers independently assessed the quality of individual studies. We included nine studies, with two from low-income high TB burden countries. Three cohort studies reported a statistically significant independent association between COPD and the risk of TB in high-income countries (n=711 389). Hazard ratios for incident TB ranged from 1.44 to 3.14 adjusted for multiple confounders including age, sex and comorbidity. There was large between-study heterogeneity (I(2)=97.0%) across studies. The direction of effect on the TB risk from asthma was inconsistent. Chronic bronchitis or bronchiectasis studies were limited. The small number of available studies demonstrated an increased risk of TB in people with COPD; however, the magnitude of the increase varies by setting and population. Data in high TB burden countries and for other CADs are limited. Oxford University Press 2021-08-12 /pmc/articles/PMC9070518/ /pubmed/34383072 http://dx.doi.org/10.1093/trstmh/trab122 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Hamada, Yohhei Fong, Christopher J Copas, Andrew Hurst, John R Rangaka, Molebogeng X Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence |
title | Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence |
title_full | Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence |
title_fullStr | Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence |
title_full_unstemmed | Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence |
title_short | Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence |
title_sort | risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070518/ https://www.ncbi.nlm.nih.gov/pubmed/34383072 http://dx.doi.org/10.1093/trstmh/trab122 |
work_keys_str_mv | AT hamadayohhei riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence AT fongchristopherj riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence AT copasandrew riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence AT hurstjohnr riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence AT rangakamolebogengx riskfordevelopmentofactivetuberculosisinpatientswithchronicairwaydiseaseasystematicreviewofevidence |